Ahmad S, Ahmad A, Ghosh M, Leslie CC, White CW. (2004) Extracellular ATP-mediated signaling for survival in hyperoxia-induced oxidative stress. J Biol Chem 279:16317–25.
Ahmad S, Ahmad A, White CW. (2006) Purinergic signaling and kinase activation for survival in pulmonary oxidative stress and disease. Free Radic Biol Med 41:29–40.
Anastasiadis PZ, Reynolds AB. (2000) The p120 catenin family: complex roles in adhesion, signaling and cancer. J Cell Sci 113 (Pt 8):1319–34.
Angiolillo DJ. (2007) ADP receptor antagonism: what’s in the pipeline? Am J Cardiovasc Drugs 7:423–32.
Antonov A, Snead C, Gorshkov B, Antonova GN, Verin AD, Catravas JD. (2008) Heat shock protein 90 inhibitors protect and restore pulmonary endothelial barrier function. Am J Respir Cell Mol Biol 39:551–9.
Beigi R, Kobatake E, Aizawa M, Dubyak GR. (1999) Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol 276:C267–78.
Bergfeld GR, Forrester T. (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26:40–7.
Birukova AA, Adyshev D, Gorshkov B, Bokoch GM, Birukov KG, Verin AD. (2006) GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 290:L540–8.
Birukova AA, Birukov KG, Adyshev D, Usatyuk P, Natarajan V, Garcia JG, Verin AD. (2005) Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction. J Cell Physiol 204:934–47.
Birukova AA, Smurova K, Birukov KG, Usatyuk P, Liu F, Kaibuchi K, Ricks-Cord A, Natarajan V, Alieva I, Garcia JG, Verin AD. (2004) Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J Cell Physiol 201:55–70.
Bodin P, Burnstock G. (1996) ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol 27:872–5.
Bodin P, Burnstock G. (1998) Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 47:351–4.
Bogatcheva NV, Adyshev D, Mambetsariev B, Moldobaeva N, Verin AD. (2007) Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 292:L487–99.
Burnstock G. (2008) Purinergic receptors as future targets for treatment of functional GI disorders. Gut 57:1193–4.
Burnstock G, Williams M. (2000) P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 295:862–9.
Carroll JS, Ku CJ, Karunarathne W, Spence DM. (2007) Red blood cell stimulation of platelet nitric oxide production indicated by quantitative monitoring of the communication between cells in the bloodstream. Anal Chem 79:5133–8.
Chatterjee A, Snead C, Yetik-Anacak G, Antonova G, Zeng J, Catravas JD. (2008) Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. Am J Physiol Lung Cell Mol Physiol 294:L755–63.
Chen Y, Harry A, Li J, Smit MJ, Bai X, Magnusson R, Pieroni JP, Weng G, Iyengar R. (1997) Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation. Proc Natl Acad Sci USA 94:14100–4.
Coade SB, Pearson JD. (1989) Metabolism of adenine nucleotides in human blood. Circ Res 65:531–7.
Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. (2002) Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J 16:583–5.
Communi D, Govaerts C, Parmentier M, Boeynaems JM. (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272:31969–73.
Communi D, Robaye B, Boeynaems JM. (1999) Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 128:1199–206.
Coughlin SR. (2000) Thrombin signalling and protease-activated receptors. Nature 407: 258–64.
da Silva CG, Specht A, Wegiel B, Ferran C, Kaczmarek E. (2009) Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation 119:871–9.
Dedkova EN, Blatter LA. (2002) Nitric oxide inhibits capacitative Ca2+ entry and enhances endoplasmic reticulum Ca2+ uptake in bovine vascular endothelial cells. J Physiol 539:77–91.
Di Benedetto G, Zoccarato A, Lissandron V, Terrin A, Li X, Houslay MD, Baillie GS, Zaccolo M. (2008) Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res 103:836–44.
Dudek SM, Camp SM, Chiang ET, Singleton PA, Usatyuk PV, Zhao Y, Natarajan V, Garcia JG. (2007) Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal 19:1754–64.
Dudek SM, Garcia JG. (2001) Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91:1487–500.
Duza T, Sarelius IH. (2003) Conducted dilations initiated by purines in arterioles are endothelium dependent and require endothelial Ca2+. Am J Physiol Heart Circ Physiol 285:H26–37.
Ecke D, Hanck T, Tulapurkar ME, Schafer R, Kassack M, Stricker R, Reiser G. (2008) Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. Biochem J 409:107–16.
Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK. (2008) A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111:2024–35.
Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, Loffler M, Reyes G, Duszenko M, Karhausen J, Robinson A, Westerman KA, Coe IR, Colgan SP. (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202:1493–505.
Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, Rosenberger P, Odegard KC, Laussen PC, Thompson LF, Colgan SP. (2006) Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108:1602–10.
Erlinge D. (2004) Extracellular ATP: a central player in the regulation of vascular smooth muscle phenotype. Focus on “Dual role of PKA in phenotype modulation of vascular smooth muscle cells by extracellular ATP”. Am J Physiol Cell Physiol 287: C260–2.
Fang Y, Olah ME. (2007) Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J Pharmacol Exp Ther 322:1189–200.
Filippov AK, Fernandez-Fernandez JM, Marsh SJ, Simon J, Barnard EA, Brown DA. (2004) Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by P2Y nucleotide receptors. Mol Pharmacol 66:468–77.
Filippov AK, Webb TE, Barnard EA, Brown DA. (1999) Dual coupling of heterologously-expressed rat P2Y6 nucleotide receptors to N-type Ca2+ and M-type K+ currents in rat sympathetic neurones. Br J Pharmacol 126:1009–17.
Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R. (2001) Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88:E68–75.
Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N. (2005) Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25:136–46.
Garcia JG, Davis HW, Patterson CE. (1995) Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163: 510–22.
Gavard J, Gutkind JS. (2008) Protein kinase C-related kinase and ROCK are required for thrombin-induced endothelial cell permeability downstream from Galpha12/13 and Galpha11/q. J Biol Chem 283:29888–96.
Germack R, Griffin M, Dickenson JM. (2004) Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes. J Mol Cell Cardiol 37:989–99.
Govers R, Rabelink TJ. (2001) Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280:F193–206.
Hammarberg C, Fredholm BB, Schulte G. (2004) Adenosine A3 receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3'-kinase. Biochem Pharmacol 67:129–34.
Hirano S, Rees RS, Yancy SL, Welsh MJ, Remick DG, Yamada T, Hata J, Gilmont RR. (2004) Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo. Cell Biol Toxicol 20:1–14.
Hoffmann C, Ziegler N, Reiner S, Krasel C, Lohse MJ. (2008) Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. J Biol Chem 283:30933–41.
Holinstat M, Mehta D, Kozasa T, Minshall RD, Malik AB. (2003) Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. J Biol Chem 278:28793–8.
Houslay MD, Baillie GS. (2003) The role of ERK2 docking and phosphorylation of PDE4 cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK signalling pathways. Biochem Soc Trans 31:1186–90.
Iwami G, Kawabe J, Ebina T, Cannon PJ, Homcy CJ, Ishikawa Y. (1995) Regulation of adenylyl cyclase by protein kinase A. J Biol Chem 270:12481–4.
Iyer S, Ferreri DM, DeCocco NC, Minnear FL, Vincent PA. (2004) VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 286:L1143–53.
Klinger M, Freissmuth M, Nanoff C. (2002) Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal 14:99–108.
Knezevic N, Roy A, Timblin B, Konstantoulaki M, Sharma T, Malik AB, Mehta D. (2007) GDI-1 phosphorylation switch at serine 96 induces RhoA activation and increased endothelial permeability. Mol Cell Biol 27:6323–33.
Koesling D, Mullershausen F, Lange A, Friebe A, Mergia E, Wagner C, Russwurm M. (2005) Negative feedback in NO/cGMP signalling. Biochem Soc Trans 33:1119–22.
Kolosova IA, Mirzapoiazova T, Adyshev D, Usatyuk P, Romer LH, Jacobson JR, Natarajan V, Pearse DB, Garcia JG, Verin AD. (2005) Signaling pathways involved in adenosine triphosphate-induced endothelial cell barrier enhancement. Circ Res 97: 115–24.
Kolosova IA, Mirzapoiazova T, Moreno-Vinasco L, Sammani S, Garcia JG, Verin AD. (2008) Protective effect of purinergic agonist ATPgammaS against acute lung injury. Am J Physiol Lung Cell Mol Physiol 294:L319–24.
Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, Sternweis PC. (1998) p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280:2109–11.
Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. (2003) Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19:541–64.
Liao Z, Seye CI, Weisman GA, Erb L. (2007) The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12. J Cell Sci 120:1654–62.
Loffler M, Morote-Garcia JC, Eltzschig SA, Coe IR, Eltzschig HK. (2007) Physiological roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol 27:1004–13.
Lynge J, Schulte G, Nordsborg N, Fredholm BB, Hellsten Y. (2003) Adenosine A 2B receptors modulate cAMP levels and induce CREB but not ERK1/2 and p38 phosphorylation in rat skeletal muscle cells. Biochem Biophys Res Commun 307:180–7.
Ma YC, Huang J, Ali S, Lowry W, Huang XY. (2000) Src tyrosine kinase is a novel direct effector of G proteins. Cell 102:635–46.
Marinissen MJ, Chiariello M, Tanos T, Bernard O, Narumiya S, Gutkind JS. (2004) The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell 14:29–41.
Minshall RD, Tiruppathi C, Vogel SM, Malik AB. (2002) Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 117:105–12.
Mong PY, Wang Q. (2009) Activation of Rho kinase isoforms in lung endothelial cells during inflammation. J Immunol 182:2385–94.
Murthy KS, Makhlouf GM. (1998) Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Preferential activation of P2Y receptors coupled to phospholipase C (PLC)-beta1 via Galphaq/11 and to PLC-beta3 via Gbetagammai3. J Biol Chem 273:4695–704.
Newton R, Stevens DA, Hart LA, Lindsay M, Adcock IM, Barnes PJ. (1997) Superinduction of COX-2 mRNA by cycloheximide and interleukin-1beta involves increased transcription and correlates with increased NF-kappaB and JNK activation. FEBS Lett 418:135–8.
Noll T, Holschermann H, Koprek K, Gunduz D, Haberbosch W, Tillmanns H, Piper HM. (1999) ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+]i. Am J Physiol 276:H1892–901.
Olanrewaju HA, Mustafa SJ. (2000) Adenosine A(2A) and A(2B) receptors mediated nitric oxide production in coronary artery endothelial cells. Gen Pharmacol 35:171–7.
Oldham WM, Hamm HE. (2008) Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol 9:60–71.
Palmer TM, Gettys TW, Stiles GL. (1995) Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor. J Biol Chem 270:16895–902.
Pearson JD, Gordon JL. (1979) Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281:384–6.
Pitcher JA, Hall RA, Daaka Y, Zhang J, Ferguson SS, Hester S, Miller S, Caron MG, Lefkowitz RJ, Barak LS. (1998) The G protein-coupled receptor kinase 2 is a microtubule-associated protein kinase that phosphorylates tubulin. J Biol Chem 273:12316–24.
Qi AD, Kennedy C, Harden TK, Nicholas RA. (2001) Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase. Br J Pharmacol 132:318–26.
Qiao J, Holian O, Lee BS, Huang F, Zhang J, Lum H. (2008) Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA. Am J Physiol Cell Physiol 295:C1161–8.
Raju NC, Eikelboom JW, Hirsh J. (2008) Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future. Nat Clin Pract Cardiovasc Med 5:766–80.
Ralevic V. (2009) Purines as neurotransmitters and neuromodulators in blood vessels. Curr Vasc Pharmacol 7:3–14.
Ray CJ, Marshall JM. (2006) The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. J Physiol 570:85–96.
Rebecchi MJ, Pentyala SN. (2000) Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80:1291–335.
Reinhard M, Jarchau T, Walter U. (2001) Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem Sci 26:243–9.
Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K, Enjyoji K. (2005) Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 31:217–33.
Ryzhov S, Zaynagetdinov R, Goldstein AE, Matafonov A, Biaggioni I, Feoktistov I. (2009) Differential role of the carboxy-terminus of the A(2B) adenosine receptor in stimulation of adenylate cyclase, phospholipase Cbeta, and interleukin-8. Purinergic Signal 5: 289–98.
Sandoval R, Malik AB, Minshall RD, Kouklis P, Ellis CA, Tiruppathi C. (2001) Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol 533:433–45.
Satpathy M, Gallagher P, Jin Y, Srinivas SP. (2005) Extracellular ATP opposes thrombin-induced myosin light chain phosphorylation and loss of barrier integrity in corneal endothelial cells. Exp Eye Res 81:183–92.
Satpathy M, Gallagher P, Lizotte-Waniewski M, Srinivas SP. (2004) Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells. Exp Eye Res 79:477–86.
Schaddelee MP, Voorwinden HL, van Tilburg EW, Pateman TJ, Ijzerman AP, Danhof M, de Boer AG. (2003) Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives. Eur J Pharm Sci 19:13–22.
Schneider GB, Hamano H, Cooper LF. (1998) In vivo evaluation of hsp27 as an inhibitor of actin polymerization: hsp27 limits actin stress fiber and focal adhesion formation after heat shock. J Cell Physiol 177:575–84.
Schneider JC, El Kebir D, Chereau C, Lanone S, Huang XL, De Buys Roessingh AS, Mercier JC, Dall’Ava-Santucci J, Dinh-Xuan AT. (2003) Involvement of Ca2+/calmodulin-dependent protein kinase II in endothelial NO production and endothelium-dependent relaxation. Am J Physiol Heart Circ Physiol 284:H2311–9.
Schulte G, Fredholm BB. (2000) Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol 58:477–82.
Schulte G, Fredholm BB. (2002) Signaling pathway from the human adenosine A(3) receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2. Mol Pharmacol 62:1137–46.
Schulte G, Fredholm BB. (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15:813–27.
Schwiebert LM, Rice WC, Kudlow BA, Taylor AL, Schwiebert EM. (2002) Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am J Physiol Cell Physiol 282:C289–301.
Shajahan AN, Timblin BK, Sandoval R, Tiruppathi C, Malik AB, Minshall RD. (2004) Role of Src-induced dynamin-2 phosphorylation in caveolae-mediated endocytosis in endothelial cells. J Biol Chem 279:20392–400.
Shajahan AN, Tiruppathi C, Smrcka AV, Malik AB, Minshall RD. (2004) Gbetagamma activation of Src induces caveolae-mediated endocytosis in endothelial cells. J Biol Chem 279:48055–62.
Singh I, Knezevic N, Ahmmed GU, Kini V, Malik AB, Mehta D. (2007) Galphaq-TRPC6-mediated Ca2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin. J Biol Chem 282:7833–43.
Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC, Colgan SP. (2004) Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200:1395–405.
Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. (1997) Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 272:25968–75.
Trevethick MA, Mantell SJ, Stuart EF, Barnard A, Wright KN, Yeadon M. (2008) Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions. Br J Pharmacol 155:463–74.
Trincavelli ML, Tuscano D, Marroni M, Klotz KN, Lucacchini A, Martini C. (2002) Involvement of mitogen protein kinase cascade in agonist-mediated human A(3) adenosine receptor regulation. Biochim Biophys Acta 1591:55–62.
Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ. (2000) SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 275:5983–6.
Verin AD, Birukova A, Wang P, Liu F, Becker P, Birukov K, Garcia JG. (2001) Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 281:L565–74.
Verin AD, Patterson CE, Day MA, Garcia JG. (1995) Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol 269:L99–108.
Verkhrasky A, Krishtal OA, Burnstock G. (2009) Purinoceptors on neuroglia. Mol Neurobiol 39:190–208.
Volonte C, Amadio S, D’Ambrosi N, Colpi M, Burnstock G. (2006) P2 receptor web: complexity and fine-tuning. Pharmacol Ther 112:264–80.
Vu TK, Hung DT, Wheaton VI, Coughlin SR. (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057–68.
Waldo GL, Harden TK. (2004) Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor. Mol Pharmacol 65:426–36.
Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D. (2002) P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40:841–53.
Weissmuller T, Eltzschig HK, Colgan SP. (2005) Dynamic purine signaling and metabolism during neutrophil-endothelial interactions. Purinergic Signal 1:229–39.
Wilson HL, Varcoe RW, Stokes L, Holland KL, Francis SE, Dower SK, Surprenant A, Crossman DC. (2007) P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells. Br J Pharmacol 151:115–27.
Wong AM, Chow AW, Au SC, Wong CC, Ko WH. (2008) Apical vs. Basolateral P2Y6 Receptor-mediated Cl- Secretion in Immortalized Bronchial Epithelia. Am J Respir Cell Mol Biol.
Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L, Mann GE. (2002) Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 16:1584–94.
Yaar R, Jones MR, Chen JF, Ravid K. (2005) Animal models for the study of adenosine receptor function. J Cell Physiol 202:9–20.
Yamamoto K, Korenaga R, Kamiya A, Qi Z, Sokabe M, Ando J. (2000) P2X(4) receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 279:H285–92.
Yao X, Huang Y. (2003) From nitric oxide to endothelial cytosolic Ca2+: a negative feedback control. Trends Pharmacol Sci 24:263–6.
Zhu B, Kelly J, Vemavarapu L, Thompson WJ, Strada SJ. (2004) Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells. Biochem Pharmacol 68:479–91.